ArticleBMC bioinformatics2025
Deep-ProBind: binding protein prediction with transformer-based deep learning model.
Article in BMC bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- MBPBERT: A Large Language Model for Metal-Binding Peptide Discovery.Interdisciplinary sciences, computational life sciences · 2026Article
- Peptide language pragmatic analysis and two-stage hierarchical learning framework for therapeutic peptide prediction.BMC biology · 2026Article
- Enhancing security information and event management with W2V-BERT-based real-time threat detection.Scientific reports · 2026Article
- LightDTA: lightweight drug-target affinity prediction via random-walk network embedding and knowledge distillation.Molecular diversity · 2026Article
- AMP-CapsNet: a multi-view feature fusion approach for antimicrobial peptide prediction using capsule networks.Genomics & informatics · 2026Article
- ProMoHGT: a heterogeneous graph transformer with graph contrastive learning for robust microbial protein function prediction.BMC genomics · 2025Article
- Integrating AI in security information and event management for real time cyber defense.Scientific reports · 2025Article
- MultiFG: integrating molecular fingerprints and graph embeddings via attention mechanisms for robust drug side effect prediction.Scientific reports · 2025Article
- Research on Plant RNA-Binding Protein Prediction Method Based on Improved Ensemble Learning.Biology · 2025Article
- N6-methyladenine identification using deep learning and discriminative feature integration.BMC medical genomics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Binding proteins play a crucial role in biological systems by selectively interacting with specific molecules, such as DNA, RNA, or peptides, to regulate various cellular processes. Their ability to recognize and bind target molecules with high specificity makes them essential for signal transduction, transport, and enzymatic activity. Traditional experimental methods for identifying protein-binding peptides are costly and time-consuming. Current sequence-based approaches often struggle with accuracy, focusing too narrowly on proximal sequence features and ignoring structural data. This study presents Deep-ProBind, a powerful prediction model designed to classify protein binding sites by integrating sequence and structural information. The proposed model employs a transformer and evolutionary-based attention mechanism, i.e., Bidirectional Encoder Representations from Transformers (BERT) and Pseudo position specific scoring matrix -Discrete Wavelet Transform (PsePSSM -DWT) approach to encode peptides. The SHapley Additive exPlanations (SHAP) algorithm selects the optimal hybrid features, and a Deep Neural Network (DNN) is then used as the classification algorithm to predict protein-binding peptides. The performance of the proposed model was evaluated in comparison with traditional Machine Learning (ML) algorithms and existing models. Experimental results demonstrate that Deep-ProBind achieved 92.67% accuracy with tenfold cross-validation on benchmark datasets and 93.62% accuracy on independent samples. The Deep-ProBind outperforms existing models by 3.57% on training data and 1.52% on independent tests. These results demonstrate Deep-ProBind's reliability and effectiveness, making it a valuable tool for researchers and a potential resource in pharmacological studies, where peptide binding plays a critical role in therapeutic development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.